Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03036358 · ClinicalTrials.gov registry record · NA
Effect of Teledermatology on Length of Hospital Admission, Length of Stay, 30 Day Readmission Rate, and Antibiotic Use in Patients Presenting With Cellulitis vs Pseudocellulitis in an Academic ED Setting
A NA study, sponsored by Ohio State University.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT03036358 is a NA study that has completed, run by Ohio State University. The registered enrollment target is 30 participants.
The verdict
NCT03036358, a NA study, has completed, sponsored by Ohio State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
The effect of teledermatology on length of hospital admission, length of stay, 30 day readmission rate, and antibiotic use in patients presenting with cellulitis vs pseudocellulitis in an academic emergency department setting.
Interventions
- OTHER Routine Care
- OTHER teledermatology consult
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2016-01 |
| Est. Completion | 2018-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03036358
The ClinicalTrials.gov registry entry for NCT03036358 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Routine Care is the first listed.
NCT03036358 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03036358 about?
NCT03036358 is a clinical study titled "Effect of Teledermatology on Length of Hospital Admission, Length of Stay, 30 Day Readmission Rate, and Antibiotic Use in Patients Presenting With Cellulitis vs Pseudocellulitis in an Academic ED Setting". The effect of teledermatology on length of hospital admission, length of stay, 30 day readmission rate, and antibiotic use in patients presenting with cellulitis vs pseudocellulitis in an academic emergency department setting.
What is the current status of trial NCT03036358?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2016-01. Estimated completion is 2018-01.
What interventions are being tested in trial NCT03036358?
The interventions under investigation include: Routine Care (OTHER), teledermatology consult (OTHER).
Who is sponsoring clinical trial NCT03036358?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.